Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
2.200
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
2.220
+0.020 (0.91%)
After-hours: Dec 5, 2025, 7:55 PM EST
Iovance Biotherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 873 | 2,255 | 2,081 | 1,009 | 2,995 | 6,806 | |
| Market Cap Growth | -66.01% | 8.40% | 106.29% | -66.33% | -55.99% | 94.85% | |
| Enterprise Value | 625 | 1,937 | 1,799 | 729 | 2,491 | 6,103 | |
| Last Close Price | 2.20 | 7.40 | 8.13 | 6.39 | 19.09 | 46.40 | |
| PS Ratio | 2.91 | 13.75 | 1749.89 | - | - | - | |
| PB Ratio | 1.21 | 3.18 | 3.56 | 2.02 | 4.82 | 10.37 | |
| P/TBV Ratio | 2.09 | 5.27 | 5.86 | 2.02 | 4.82 | 10.37 | |
| EV/Sales Ratio | 2.50 | 11.81 | 1512.80 | - | - | - | |
| Debt / Equity Ratio | 0.08 | 0.08 | 0.13 | 0.17 | 0.12 | 0.08 | |
| Asset Turnover | 0.26 | 0.19 | 0.00 | - | - | - | |
| Inventory Turnover | 4.40 | 4.01 | - | - | - | - | |
| Quick Ratio | 2.92 | 3.21 | 2.54 | 5.16 | 5.66 | 11.47 | |
| Current Ratio | 3.41 | 3.74 | 2.79 | 5.24 | 5.70 | 11.59 | |
| Return on Equity (ROE) | -53.89% | -57.48% | -81.91% | -70.61% | -53.55% | -54.34% | |
| Return on Assets (ROA) | -27.12% | -29.22% | -39.86% | -34.59% | -27.71% | -29.42% | |
| Return on Capital (ROIC) | -31.99% | -34.57% | -46.22% | -39.01% | -30.57% | -32.14% | |
| Return on Capital Employed (ROCE) | -52.80% | -50.20% | -68.70% | -69.70% | -49.80% | -36.70% | |
| Earnings Yield | -45.53% | -16.50% | -21.34% | -39.25% | -11.43% | -3.81% | |
| FCF Yield | -40.29% | -16.14% | -18.46% | -31.05% | -8.87% | -3.70% | |
| Buyback Yield / Dilution | -19.46% | -23.28% | -47.64% | -3.82% | -10.92% | -11.23% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.